New information on breast cancer detection, treatment, and prevention can help you remain healthy and cancer-free.
As a company who works with breast cancer survivors every day, we like to stay up-to-date on the newest breast cancer research. Some interesting topics in breast cancer research news involve alternatives to breast reconstruction, reducing the risk of breast cancer, improved imaging tests for breast cancer, and new medications to fight breast cancer.
3-D Mammograms Improve Detection of Breast Cancer in Women Under 50
Digital breast tomosynthesis (three-dimensional mammography) produces a detailed 3-D image using x-ray technology. Doctors apply several pictures of the breast taken from different angles to create a three-dimensional picture.
This allows them to detect small or hidden breast cancers in premenopausal women. Conventional mammograms offer only two dimensional images of a breast using just two x-ray pictures of each breast. Digital breast tomosynthesis has been approved by the FDA and is rapidly being adopted by mammogram centers and hospitals. In addition, studies are finding that 3-D mammograms discover more cancers than 2-D mammograms while also reducing false positive diagnoses.
New Drug Recently Approved for Treating Breast Cancer
Kisqali, an oral drug approved by the U.S. Food and Drug Administration in March, can now be used as an adjunct medication with an aromatase inhibitor for treating advanced or metastatic HER2 (hormone-receptor-positive) negative breast cancer affecting postmenopausal women who have not yet began hormonal therapy.
Specifically, Kisqali is a unique type of kinase inhibitor, meaning it targets proteins (kinase) that regulate cell division. Since cancer is essentially a disease involving abnormally rapid division of cells, Kisqali can help stop cancer cells from proliferating.
Aromatase inhibitors are medications prescribed for HRP breast cancer. Arimidex, Aromasin and Femara are the only three aromatase inhibitors available. A study involving postmenopausal women with HER2-negative breast cancer taking Femara and Kisqali together found that 44 percent more lowered the risk of their cancer progressing than women taking Femara alone. However, like most cancer treatments, Kisqali may cause unwanted side effects, such as nausea, fatigue, hair loss, vomiting, diarrhea and back pain.
Exercise and Maintaining Healthy Weight May Reduce the Risk of Recurring Breast Cancer
Many research studies have discovered a positive correlation between regular exercise and reduced risk of breast cancer coming back and being diagnosed with several types of breast cancer. The American Cancer Society now recommends that women diagnosed with breast cancer engage in moderate exercise at least four hours per week. Brisk walking, bicycling, mopping/vacuuming/heavy housework and playing tennis are examples of moderate exercise activities.
Exercise induces beneficial biological effects on your body, which explains why physical activity can help treat and reduce the risk of breast cancer. These effects include:
- Decreasing levels of growth factors estrogen and insulin, associated with development of colon and breast cancer.
- Reducing the risk of insulin resistance, a disease that increases insulin levels in the bloodstream.
- Reducing systemic inflammation that may play a role in breast cancer development.
If you have had a mastectomy due to breast cancer and want to know the alternatives to breast reconstruction, please contact ContourMed today by calling (877)-380-8528 for information about our custom breast prostheses.